市場調查報告書
商品編碼
1209791
全球整容手術市場:到 2028 年的預測——手術類型(非侵入性、侵入性)、性別(女性、男性)、年齡組(13-29、30-54、55+)、最終用戶分析、地區Cosmetic Surgery Market Forecasts to 2028 - Global Analysis By Procedure Type (Non-invasive Procedures and Invasive procedures), Gender (Female and Male), Age Group (13-29, 30-54 and 55 and above), End User and Geography |
根據 Stratistics MRC 的數據,全球整容手術市場規模將在 2022 年達到 568.5 億美元,到 2028 年達到 792.9 億美元,預測期內復合年增長率為 5.7%。
整容手術是指患者為修改、塑造輪廓或改善其外貌而進行的任何手術。 整容手術是醫學的一個分支,專注於通過手術和藥物治療改善外觀。 整容手術可以在頭部、頸部或身體的任何部位進行。 整容手術是可選的,因為治療區域缺乏正常功能和美感。 整容手術包括範圍廣泛的程序。
根據國際美容整形外科學會(ISAPS)2020年公佈的數據,男性最常進行的手術大約有225,177次吸脂手術、905,958次肉毒桿菌毒素注射和298,070次脫毛手術。據悉,有
市場動態
驅動程序
越來越關注審美功能
近年來,隨著美容成為日常生活的重要組成部分,美容手術的需求也逐漸發生變化。 越來越多的人開始關注審美特徵,從而創造了潛在的商機。 女性對隆胸、吸脂、雙眼皮、腹部整形等整容手術的偏好正在推動整容手術的市場需求。 出於多種原因,非手術治療是首選,包括更快的恢復時間、更少的疼痛和更低的醫療費用。 除了上述因素外,主要公司加大研發投入和新產品推出也在推動市場擴張。
抑製劑
整容手術相關的並發症
整容手術期間和之後可能會出現各種問題。 在沙龍和水療中心等非醫療環境中進行的非醫生手術正在產生越來越多的問題。 疤痕、腫脹、感染和神經損傷是整容手術最常見的一些後果。 此外,使用面部填充物的副作用一直是限制市場擴張的主要障礙。 發紅、皮膚色素沉著、瘀傷、歪斜的笑容、炎症反應和其他問題很普遍。 人們擔心安全,這減少了接受整容手術的人數。 這是整容手術需求下降的主要原因之一。
機會
男性對整容手術的需求不斷增長
由於年齡問題,美容治療在男性人群中的普及和採用逐年增加,男性選擇這些手術來保持年輕的容貌。 此外,男性對皮膚填充劑和肉毒桿菌毒素治療等非手術程序的需求不斷增長,這推動了執行程序的數量,促進了整個市場的發展。 這些變量,連同穩步改善的性別平衡,正在推動男性人群對整容手術的總需求。
威脅
混亂市場的存在
在各個國家/地區,提供整容手術的非法經銷商數量不斷增加,吸引了很大一部分希望進行整容手術的人。 此類設施,例如無執照的從業者和外科醫生,正在對市場產生負面影響。 由於患者接受不合格的材料和植入物,這些方面導致越來越多的整容手術失敗。 與無序市場相關的整容手術不良影響的發生越來越多,預計將在預測期內抑制整容手術市場的增長。
COVID-19 的影響
預計 COVID-19 疫情將對全球整容手術市場的增長產生不利影響。 許多診所和醫院已經重組,以增加 COVID-19 患者的醫院容量。 由於 COVID-19 流行病而實施的封鎖減少了流行病期間患者就診整容手術的頻率。 整容手術是一種非緊急手術,會對化妝品公司的盈利能力產生重大影響。 在過去的幾個月裡,人們對非侵入性手術的興趣有所增加,而對侵入性手術的興趣有所下降。
預計在預測期內非侵入性手術部分將是最大的部分
由於接受皮膚填充劑、肉毒桿菌毒素和透明質酸等非侵入性手術的患者越來越多,而且越來越多的患者越來越多,預計非侵入性手術部分將實現有利增長。 這種日益普及可能歸因於它提供的幾個好處,包括更快的恢復時間、更低的住院率和無痛治療。 肉毒桿菌毒素注射、軟組織填充劑、化學換膚和其他非侵入性手術很受歡迎。
預計在預測期內,醫院和診所部門的複合年增長率最高
由於整容手術的增加以及執行各種外科手術的醫院和診所的增加,預計醫院和診所部分在預測期內將呈現最快的複合年增長率。 與其他設施相比,醫院和診所進行大部分美容治療。 此外,對微創手術的需求不斷增加以及患者對診所的偏好正在推動該行業的擴張。
市場份額最高的地區
由於執行各種美容手術的高素質整形外科醫生以及美國和加拿大美容診所的增加,預計北美在預測期內將佔據最大的市場份額。 此外,先進的醫療基礎設施、美容治療的接受度、皮膚問題患病率上升以及獲得董事會認證的專業美容外科醫生的存在是推動該地區市場擴張的一些主要因素。
複合年增長率最高的地區
歐洲預計將在預測期內創下最高複合年增長率。 非侵入性治療的日益普及以及在德國和法國等國家開設新的醫療水療中心正在推動該地區的市場擴張。 技術先進的產品的可用性和對外觀吸引力的日益重視可能會推動該地區的市場。
主要發展
2022 年 7 月,Cutera 宣布批准 AviClear,這是美國第一個也是唯一一個用於治療輕度、中度和重度痤瘡的激光治療設備。
2022 年 6 月,Cynosure 推出了 PicoSure Pro,它具有由鉑金製成的先進透鏡聚焦陣列,據信可通過增加膠原蛋白和彈性蛋白含量來幫助縮小皺紋、痤瘡疤痕和毛孔。設備“已經發布。
2021 年 2 月,Merz Pharma 宣佈在美國推出 BELOTERO BALANCE+利多卡因。 BELOTERO BALANCE 是一種用於蝕刻線的透明質酸 (HA) 填充劑,由於利多卡因配方的好處,可為填充劑患者提供完美的表面處理。
2020年7月,Bosch Medical旗下的Solta Medical發布了一款射頻緊膚儀——Thermage FLX系統。 Thermage FLX 是唯一獲得 FDA 批准的眼瞼治療系統。
本報告的內容
免費定制服務
訂閱此報告的客戶將免費獲得以下自定義選項之一。
According to Stratistics MRC, the Global Cosmetic Surgery Market is accounted for $56.85 billion in 2022 and is expected to reach $79.29 billion by 2028 growing at a CAGR of 5.7% during the forecast period. Cosmetic surgery is a voluntary operation that patients undergo in order to modify their bodies, contour their bodies, and improve their physical appearance. Cosmetic surgery is a distinct branch of medicine that focuses on improving appearance through surgical and medicinal treatments. Cosmetic surgery can be performed on any part of the head, neck, or body. Cosmetic surgery is optional because treated parts function normally but lack aesthetic appeal. Cosmetic surgery encompasses a wide range of procedures.
According to the data published by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, it was reported that around 225,177 liposuction, 905,958 botulinum toxin, and 298,070 hair removal were among the most common procedures performed on men.
Market Dynamics:
Driver:
Rising focus on aesthetic features
As beauty has become a significant component of daily life, the demand for cosmetic operations has gradually changed in recent years. The increase in population focusing on aesthetic characteristics has created potential business prospects. Women's preference for aesthetic procedures such as breast augmentation, liposuction, eyelid surgery, abdominoplasty, and others is driving up market demand for cosmetic procedures. People prefer non-surgical therapies for a variety of reasons, including shorter recovery times, less pain, and lower healthcare expenses. The factors listed above, as well as increased R&D investments and new product launches by key players, are driving and contributing to market expansion.
Restraint:
Complications associated with cosmetic procedure
A variety of issues may arise during or after the cosmetic surgery. Non-physician operations performed in salons, spas, and other non-medical environments are producing an increasing number of issues. Scars, swelling, infections, and nerve damage are some of the most common consequences of cosmetic operations. Furthermore, the adverse effects of utilising face fillers are a major barrier limiting market expansion. Redness, skin pigmentation, bruising, crooked smile, inflammatory reaction, and other problems are prevalent. People have safety concerns, which reduces the number of people who have cosmetic operations. This aspect has played a significant role in lowering the demand for cosmetic surgeries.
Opportunity:
Increasing demand for cosmetic procedures among male population
Because of age-related concerns, the popularity and adoption of cosmetic treatments among the male population is increasing year after year, and men are choosing these procedures to keep their youthful appearance. Furthermore, rising demand for nonsurgical procedures such as dermal fillers and botulinum toxin procedures among men is driving up the number of procedures performed and contributing to total market development. The aforementioned variables, as well as the steadily better gender balance, are increasing the total demand for cosmetic operations among the male population.
Threat:
Presence of an unregulated market
Various countries have seen an increase in the number of illegal sellers offering cosmetic operations and luring a sizable section of the population eager to undergo aesthetic procedures. These facilities, such as unlicensed medical practitioners and surgeons, have a negative impact on the market. This aspect contributes to an increase in the number of cosmetic procedures that go wrong, with patients accepting substandard materials and implants. Increasing incidences of undesirable effects of aesthetic surgery associated to an uncontrolled market are expected to restrain the growth of the cosmetic surgery market during the projected period.
COVID-19 Impact
The COVID-19 epidemic is expected to have a detrimental impact on the growth of the worldwide cosmetic surgery market. A number of clinics and hospitals were restructured in order to boost hospital capacity for COVID-19 patients. The implementation of lockdown due to the COVID-19 epidemic resulted in a decrease in the frequency of patient visits for aesthetic operations during the pandemic. Cosmetic surgical operations are non-emergency procedures that have considerably affected the profitability of aesthetic companies. Interest in non-invasive procedures has increased during the past few months while interest in invasive procedures has declined.
The non-invasive procedures segment is expected to be the largest during the forecast period
The non-invasive procedures segment is estimated to have a lucrative growth, due to the growing popularity and higher patient population undergoing non-invasive procedures such as dermal filler, botulinum toxin, hyaluronic acid, and others. This increased popularity can be attributed to the several advantages provided, such as shorter recovery times, lower hospitalisation rates, painless treatments, and more. Botox injections, soft tissue fillers, chemical peels, and other non-invasive procedures are popular.
The hospitals & clinic segment is expected to have the highest CAGR during the forecast period
The Hospitals & Clinic segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in number of cosmetic surgeries, and rise in number of hospitals and clinics to conduct various surgical procedures. In comparison to other facilities, hospitals and clinics execute the majority of cosmetic treatments. Furthermore, the increased demand for minimally invasive procedures, as well as patients' preference for clinics, is driving category expansion.
Region with highest share:
North America is projected to hold the largest market share during the forecast period owing to the presence of highly qualified plastic surgeons performing various cosmetic procedures and the growing number of aesthetic clinics in the U.S. and Canada. Furthermore, sophisticated healthcare infrastructure, cosmetic treatment acceptance, rising prevalence of skin problems, and the existence of board-certified and professional cosmetic surgeons in the region are some of the primary factors driving market expansion.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period. The growing popularity of noninvasive procedures, as well as the opening of new medical spas in countries such as Germany and France, is driving market expansion in this region. The availability of technologically sophisticated items, as well as the increased emphasis on physical attractiveness, is expected to drive the regional market.
Key players in the market
Some of the key players profiled in the Cosmetic Surgery Market include Syneron Candela, Solta Medical, AbbVie, Lumenis, Cynosure, Evolus, Inc., Galderma S.A., Bausch Health Companies Inc., Alma Lasers, MerzPharma GmbH & Co. KGaA, Johnson and Johnson, Apyx Medical
Key Developments:
In July 2022, Cutera announced the approval for AviClear, the first and only laser treatment device approved in the U.S. to cure mild, moderate, and severe acne.
In June 2022, Cynosure launched the PicoSure Pro Device, which has an advanced lens focus array made of Platinum which would help to reduce wrinkles, acne scars and pores by increasing the content of collagen and elastin.
In February 2021, Merz Pharma announced the launch of BELOTERO BALANCE + Lidocaine in the U.S. The BELOTERO BALANCE is a hyaluronic acid (HA) filler for etchedin lines & advantages of lidocaine formulation provides a perfect finish to filler patients.
In July 2020, Bausch Health Companies Inc.'s Solta Medical has released the radiofrequency device-Thermage FLX system, designed to tighten skin. Thermage FLX is the only FDA-approved system for the treatment of eyelids.
Procedure Types Covered:
Genders Covered:
Age Groups Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: